gene expression profiling of HNSCC samples confirmed the presence of TLSs, identified through canonical TLS signatures including lymphoid aggregates with upregulated markers such as CXCL13, CCL19, and CCL21 (23). This evidence concerns the gene CCL19 and head and neck squamous cell carcinoma.